COVID-19, saying it can reduce the risk of hospitalization. But, just how much of a gamechanger could it really be?READ MORE: Merck seeks FDA authorization of antiviral COVID-19 pill"If this pill is something that gets approved and becomes available, it will be something very similar to what we do for influenza," says Dr.
Amesh Adalja of Johns Hopkins Center for Health Security. "For example, you get diagnosed with influenza, you get a prescription for Tamiflu."The company reported earlier this month that the pill cut hospitalizations and deaths by half among patients with early symptoms of COVID-19.